Prescription Drug Search
Product Request Form
Vandetanib is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Vandetanib becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about NationDrugs.to
List of countries where we can ship Vandetanib:
- Albania
- Algeria
- Anguilla
- Armenia
- Aruba
- Bahrain
- Bermuda
- Brazil
- Cayman Islands
- Chile
- China
- Colombia
- Cook Islands
- Costa Rica
- Cyprus
- Dominican Republic
- Ecuador
- Germany
- Grenada
- Guadeloupe
- Hong Kong
- India
- Iran
- Ireland
- Italy
- Latvia
- Lebanon
- Lithuania
- Luxembourg
- Mauritius
- Morocco
- Norway
- Peru
- Poland
- Portugal
- Singapore
- Slovakia
- Turkey
- United Arab Emirates
- United Kingdom, UK
Latest news releases on Vandetanib:
Vandetanib - Wikipedia
Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of ...
Vandetanib - FDA prescribing information, side effects and ...
Vandetanib official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Caprelsa - min.medicin.dk – information om medicin
Tabletter. 1 tablet (filmovertrukken) indeholder 100 mg eller 300 mg vandetanib. ...
Vandetanib | C22H24BrFN4O2 - PubChem - The PubChem Project
Vandetanib is a multi-kinase inhibitor that is used in the therapy of advanced or metastatic medullary thyroid cancer. Vandetanib therapy is commonly associated with ...
CAPRELSA® (vandetanib) REMS Program | Advanced Medullary ...
Information for the CAPRELSA REMS Program. CAPRELSA ® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid ...
Caprelsa - pro.medicin.dk – information om medicin
Aggressiv og symptomatisk medullær thyroideacancer (MTC) hos patienter med inoperabel lokalt fremskreden eller metastaserende sygdom. Vandetanib bør kun anvendes ...
About CAPRELSA | CAPRELSA.com
Important Safety Information. Important Safety Information: CAPRELSA ® (vandetanib) Tablets can cause a change in the electrical activity of your heart called QT ...
Vandetanib dosing, indications, interactions, adverse ...
Medscape - Medullary thyroid cancer dosing for vandetanib, frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ...
Vandetanib - DrugBank
Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. On ...
Vandetanib - National Cancer Institute
This page contains brief information about vandetanib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
